Additionally, SEMA6A plays a pivotal role in orchestrating the coordinated escape of melanoma cells from concurrent BRAF/MEK inhibition, signifying its potential as a dependable marker for immediate therapeutic benefits of such inhibition. The gene discussed is MAP2K7; the disease is melanoma.